Exploratory OCD study
Open this page in the complete interactive Atlas
Describes trial phases and how investigators defined response and remission on the Yale-Brown scale.
Where this source fits
Psilocybin · Obsessive-compulsive disorder
At the end of eight weeks, 11 of 15 met the study response threshold and 6 met remission criteria on the OCD symptom scale.
Those percentages combine experience across phases after all participants received active treatment. They cannot be interpreted as placebo-adjusted response rates.
Reading basis · Original source summarized in the experimental-drug section